Simvastatin reduces ergosterol levels, inhibits growth and causes loss of mtDNA in Candida glabrata

FEMS Yeast Research

Volumn 7, Issue 3, 2007, Pages 436-441

  Westermeyer, Christiane ^a   Macreadie, Ian G ^a  

^a CSIRO   (Australia)

Author keywords

Atorvastatin; Cholesterol; HMG CoA reductase inhibition; Petite induction; Simvastatin; Yeast

Indexed keywords

ATORVASTATIN; ERGOSTEROL; FUNGAL DNA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MITOCHONDRIAL DNA; SIMVASTATIN;

ARTICLE; CANDIDA GLABRATA; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; FUNGUS CULTURE; FUNGUS GROWTH; GENE DELETION; GENOME; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MITOCHONDRIAL GENETICS; NONHUMAN; STAINING; YEAST;

CANDIDA GLABRATA; DNA, MITOCHONDRIAL; ERGOSTEROL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; SIMVASTATIN;

CANDIDA GLABRATA;

EID: 34147144067     PISSN: 15671356     EISSN: 15671364     Source Type: Journal    
DOI: 10.1111/j.1567-1364.2006.00194.x     Document Type: Article

References (29)

1. Arthington-Skaggs BA, Jradi H, Desai T & Morrison CJ (1999) Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans. J Clin Microbiol 37: 3332-3337.
2. Baranova NA, Kreiner VG & Egorov NS (1996) The growth of Rhodotorula rubra yeasts and their synthesis of ergosterol on media with lovastatin. Antibiot Khimioter 41: 3-6.
3. Bibikova MV, Chmel' Ia V, Spiridonova IA & Katlinskii AV (2004) Lovastatin effect on ergosterol production and growth of Tolypocladium inflatum 106. Antibiot Khimioter 49: 3-6.
4. Bouchara JP, Zouhair R, Le Boudouil S, Renier G, Filmon R, Chabasse D, Hallet JN & Defontaine A (2000) In-vivo selection of an azole-resistant petite mutant of Candida glabrata. J Med Microbiol 49: 977-984.
5. Breivik ON & Owades JL (1957) Spectrophotometric semimicrodetermination of ergosterol in yeast. Agric Food Chem 5: 360-363.
6. Brun S, Aubry C, Lima O, Filmon R, Berges T, Chabasse D & Bouchara JP (2003) Relationships between respiration and susceptibility to azole antifungals in Candida glabrata. Antimicrob Agents Chemother 47: 847-853.
7. Brun S, Berges T, Poupard P, Vauzelle-Moreau C, Renier G, Chabasse D & Bouchara JP (2004) Mechanisms of azole resistance in petite mutants of Candida glabrata. Antimicrob Agents Chemother 48: 1788-1796.
8. Corsini A (2003) The safety of HMG-CoA reductase inhibitors in special populations at high cardiovascular risk. Cardiovasc Drugs Ther 17: 265-285.
9. Defontaine A, Bouchara JP, Declerk P, Planchenault C, Chabasse D & Hallet JN (1999) In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata. J Med Microbiol 48: 663-670.
10. Hengst L, Dulic V, Slingerland JM, Lees E & Reed SI (1994) A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc Natl Acad Sci USA 91: 5291-5295.
11. Jimenez J, Longo E & Benitez T (1988) Induction of petite yeast mutants by membrane-active agents. Appl Environ Microbiol 54: 3126-3132.
12. Koning AJ, Roberts CJ & Wright RL (1996) Different subcellular localization of Saccharomyces cerevisiae HMG-CoA reductase isozymes at elevated levels corresponds to distinct endoplasmic reticulum membrane proliferations. Mol Biol Cell 7: 769-789.
13. Kontoyiannis DP (2000)Modulation of fluconazole sensitivity by the interaction of mitochondria and erg3p in Saccharomyces cerevisiae. J Antimicrob Chemother 46: 191-197.
14. Kreiner VG, Vybornykh SN, Baranova NA & Egorov NS (1993) The effect of lovastatin on sterol synthesis and yeast resistance to polyene antibiotics. Antibiot Khimioter 38: 16-19.
15. Linnane AW Treatment of statin side effects using uridine derivatives. International Patent WO 03/049730 A1 June 19, 2003.
16. Lorenz RT & Parks LW (1990) Effects of lovastatin (mevinolin) on sterol levels and on activity of azoles in Saccharomyces cerevisiae. Antimicrob Agents Chemother 34: 1660-1665.
17. Lum PY, Edwards S & Wright R (1996) Molecular, functional and evolutionary characterization of the gene encoding HMG-CoA reductase in the fission yeast, Schizosaccharomyces pombe. Yeast 12: 1107-1124.
18. Macreadie IG, Johnson G, Schlosser T & Macreadie PI (2006) Growth inhibition of Candida species and Aspergillus fumigatus by statins. FEMS Microbiol Lett 262: 9-13.
19. McLean-Bowen CA & Parks LW (1981) Corresponding changes in kynurenine hydroxylase activity, membrane fluidity, and sterol composition in Saccharomyces cerevisiae mitochondria. J Bacteriol 145: 1325-1333.
20. Meeusen S & Nunnari J (2003) Evidence for a two membrane-spanning autonomous mitochondrial DNA replisome. J Cell Biol 163: 503-510.
21. O'Connor RM, McArthur CR & Clark-Walker GD (1976) Respiratory-deficient mutants of Torulopsis glabrata, a yeast with circular mitochondrial deoxyribonucleic acid of 6 μm. J Bacteriol 126: 959-968.
22. Owczarek J, Jasinska M & Orszulak-Michalak D (2005) Drug-induced myopathies. An overview of the possible mechanisms. Pharmacol Rep 57: 23-34.
23. Qiu MS, Pitts AF, Winters TR & Green SH (1991) Ras isoprenylation is required for ras-induced but not for NGF-induced neuronal differentiation of PC12 cells. J Cell Biol 115: 795-808.
24. Ravnan SL, Locke C, Yee WP & Haase K (2002) Cerivastatin-induced rhabdomyolysis: 11 case reports. Pharmacotherapy 22: 533-537.
25. Roze LV & Linz JE (1998) Lovastatin triggers an apoptosis-like cell death process in the fungus Mucor racemosus. Fungal Genet Biol 25: 119-133.
26. Sinzinger H & O'Grady J (2004) Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems. Br J Clin Pharmacol 57: 525-528.
27. Sinzinger H, Wolfram R & Peskar BA (2002) Muscular side effects of statins. J Cardiovasc Pharmacol 40: 163-171.
28. Summers C, Karst F & Charles AD (1993) Cloning, expression and characterisation of the cDNA encoding human hepatic squalene synthase, and its relationship to phytoene synthase. Gene 136: 185-192.
29. Thompson ED & Parks LW (1974) Effect of altered sterol composition on growth characteristics of Saccharomyces cerevisiae. J Bacteriol 120: 779-784.